2 completed. 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Hercules: new trials by email Literature Review of Hercules trials Research Report on Hercules
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1 Study of Trastuzumab Administered as a Single Intravenous Infusion Hercules, Herceptin EU, Herceptin US - Healthy | Phase 1 | Completed | Mylan Pharmaceuticals Inc | 132 | 2013-08-01 | 2015-11-03 |
| Study of Efficacy and Safety of Myl1401O + Taxane vs Herceptin©+ Taxane for 1st Line, Met. Br. Ca. Trastuzumab, MYL- 1401O, Paclitaxel - Breast Cancer | Phase 3 | Completed | Mylan Inc. | 500 | 2012-07-01 | 2022-02-14 |
Breast Neoplasms (1)
Mylan Inc. (1) · Mylan Pharmaceuticals Inc (1)
Brazil (1) · Chile (1) · Georgia (1) · Hungary (1) · India (1) · Latvia (1) · Peru (1) · Romania (1) · Russia (1) · Serbia (1) · Slovakia (1) · South Africa (1) · Thailand (1) · Turkey (Türkiye) (1) · Ukraine (1)
Apinya Vutikullird, D.O. (1) · Eduardo Pennella, MD (1)